EVENT DETAILS
Tuesday, November 13, 2018
Westford Regency Inn & Conference Center
219 Littleton Road,
Westford, MA 01886
Time
8:00 AM - 5:00 PM
Total Credits
7 Contact Hour(s)
Target Audience
Nurse , Pharmacist , Pharmacy Technician
Cost
$129.00
Registration closes on 11/12/2018 at 11:00 PM
 

Registration will be held from 8:00 am - 8:30 am. Continental breakfast will be served during this time.

A plated lunch will be served from 12:00 pm - 1:00 pm.

Refreshments will be served during the afternoon programs.

 

AGENDA

Scheduled CE Activities Tuesday, November 13, 2018
  
HIV treatment and prevention continues to evolve in 2018, with new medications being approved and use of HIV medications for prevention being used in many cities across the US. Attaining and maintaining HIV viral suppression is still the main treatment goal of not only HIV treatment, but also for preventing new infections. This presentation will review recent consensus guidelines for managing HIV infected patients and for preventing new infections. Drug interactions and provider resources will also be reviewed. Using case scenarios, pharmacists will be able to compare and contrast different regimens for HIV and the rationale for their selection. 
 
 
Pharmacist Learning Objectives
  • Recognize current guidelines for HIV treatment and for prevention
  • Describe the role of newer medication for HIV infection
  • Define the rationale for treatment as prevention, PrEP and U=U
  • List the top 10 significant drug interactions with HIV medications
  • Identify online resources to assist pharmacists in managing HIV
Pharmacy Technician Learning Objectives
  • Recognize current public resources for HIV prevention
  • Identify medication for HIV infection by generic name and classification
  • Define the rationale for treatment as prevention
  • List the top 10 significant drug interactions with HIV medications
  • Identify online resources to assist patients in managing HIV
Nurse Learning Objectives
  • Recognize current guidelines for HIV treatment and for prevention
  • Describe the role of newer medication for HIV infection
  • Define the rationale for treatment as prevention, PrEP and U=U
  • List the top 10 significant drug interactions with HIV medications
  • Identify online resources to assist pharmacists in managing HIV
 
Faculty
John FaragonPharmD, BCPS, AAHIVP
Regional Pharmacy Director, North East Caribbean AIDS Education and Training Center
 
ACPE UAN
0280-9999-18-083-L02-P (Knowledge-Based)
0280-9999-18-083-L02-T (Knowledge-Based)
0280-9999-18-083-L02-N (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Supported By
Aids and Education Training Center
 
Depression impacts an estimated 6.7% of the U.S. population, making it the most common mental disorder in the United States, with many cases being undiagnosed and/or untreated. Tragically, a diagnosis of depression increases an individual's risk for suicide by almost twenty-fold. Suicide, however, is a completely preventable phenomenon. Statistically, pharmacists and pharmacy technicians find themselves staring at the perilous front line of this battle on a continuous basis. The very front line of the battle, however, often goes unrecognized and unaddressed.

This session seeks to review the functionality of major classes of antidepressant medications, highlighting the most common prescribing concerns among the various classes. Additionally, the session seeks to evaluate the pharmacist and pharmacy technician's role in recognizing suicidal behaviors and appropriate follow up actions. 

 
 
Pharmacist Learning Objectives
  • Identify the symptoms and characteristics of depression.
  • Critically evaluate the relationship between depression, antidepressant medications, and suicide risk.
  • Identify appropriate professional discussion and interventions in communicating with patients at an increase risk for suicide.
Pharmacy Technician Learning Objectives
  • Identify the symptoms and characteristics of depression.
  • Critically evaluate the relationship between depression, antidepressant medications, and suicide risk.
  • Identify appropriate professional discussion and interventions in communicating with patients at an increase risk for suicide.
 
Faculty
Kevin HopeRPh
Clinical Education Specialist and Continuing Education Administrator, PharmCon, Inc.; Advisory Board Member, Paradigm Education Solutions; Nuclear Pharmacist, Triad Isotopes
 
ACPE UAN
0280-0000-18-008-L01-P (Knowledge-Based)
0280-0000-18-008-L01-T (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Supported By
American Health Resources, LLC.
 
For nearly 30 years, HbA1c has been the accepted gold-standard measurement of diabetes outcomes. Patients and clinicians have relied on the 3-month average blood glucose to assess the efficacy of diabetes therapies and inform treatment decisions, and it has become the primary endpoint for most diabetes drug approval studies. But HbA1c alone should not be the only consideration based on newer evidence and other outcomes such as cardiovascular, renal, hypoglycemia, and changes in body weight should be considered when treating the patient.
 
 
Pharmacist Learning Objectives
  • Recognize key elements of the ADA and AACE guidelines and identify new evidence of pharmacotherapies that pertain to non-glycemic outcomes
  • Recognize treatment options that optimize outcomes beyond A1c such as hypoglycemia, weight as well as cardiovascular and renal outcomes in patients with type 2 diabetes
  • Identify appropriate elements of an evidence-based treatment regimen that optimizes outcomes beyond hemoglobin A1c in patients with type 2 diabetes
Pharmacy Technician Learning Objectives
  • Recognize key elements of the newest ADA and AACE guidelines within the context of identifying patients who may benefit from a referral for pharmacist consultation.
  • Recognize treatment options for type 2 diabetes by generic name and drug classification.
  • Identify common factors for patients with type 2 diabetes that warrant referral to the pharmacist for consultation.
Nurse Learning Objectives
  • Recognize key elements of the ADA and AACE guidelines and identify new evidence of pharmacotherapies that pertain to non-glycemic outcomes
  • Recognize treatment options that optimize outcomes beyond A1c such as hypoglycemia, weight as well as cardiovascular and renal outcomes in patients with type 2 diabetes
  • Identify appropriate elements of an evidence-based treatment regimen that optimizes outcomes beyond hemoglobin A1c in patients with type 2 diabetes
 
Faculty
Dhiren PatelPharmD, CDE, BC-ADM, BCACP
Associate Professor of Pharmacy Practice, MCPHS University
 
ACPE UAN
0280-0000-18-082-L01-P (Knowledge-Based)
0280-0000-18-082-L01-T (Knowledge-Based)
0280-0000-18-082-L01-N (Knowledge-Based)
 
Credits
2
 
Handouts
 
Supported By
American Health Resources
 
As the nation’s opiate crisis continues, pharmacy personnel often find themselves thrust into a rapidly evolving regulatory theater as various agencies seek to reduce the impact of the current crisis in the United States.  This session seeks to identify the most common methods of diversion and to examine the “red flags” that pharmacy personnel should recognize as being potentially indicative of inappropriate access.  The concept of a pharmacist’s ‘corresponding responsibility’ will be carefully examined, including DEA expectations for recordkeeping upon facility audit.  The importance of proper drug disposal will be addressed within the context of preventing unintended diversion.
 
 
Pharmacist Learning Objectives
  • Recognize required recordkeeping regulations and expectations for a DEA pharmacy audit.
  • Recognize potential “red flags” as they relate to prescriptions and/or customers
  • List common drugs of abuse and methods of diversion.
  • Identify appropriate disposal options for controlled substances.
Pharmacy Technician Learning Objectives
  • Recognize required recordkeeping regulations and expectations for a DEA pharmacy audit.
  • Recognize potential “red flags” as they relate to prescriptions and/or customers
  • List common drugs of abuse and methods of diversion.
  • Identify appropriate disposal options for controlled substances.
Nurse Learning Objectives
  • Recognize required recordkeeping regulations and expectations for a DEA pharmacy audit.
  • Recognize potential “red flags” as they relate to prescriptions and/or customers
  • List common drugs of abuse and methods of diversion.
  • Identify appropriate disposal options for controlled substances.
 
Faculty
Claire BrennanDiversion Program Manager
Drug Enforcement Administration
 
ACPE UAN
0280-9999-18-081-L03-P (Knowledge-Based)
0280-9999-18-081-L03-T (Knowledge-Based)
0280-9999-18-081-L03-N (Knowledge-Based)
 
Credits
2
 
Handouts
 
Supported By
Drug Enforcement Administration
 
 
 
 
Requirements for CE Credit
  • Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their
  • Pharmacists and Pharmacy Technicians: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.
  • Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
  • Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, LLC at least 48 hours prior to the program or if the program is cancelled. American Health Resources, LLC reserves the right to change the presenters, topics or seminar schedules.
 
Only Certificates of Credit issued from CPE Monitor are valid in the US.
CPE Monitor will not accept credits after 60 days from the session date.
 
Supported By:
American Health Resources, LLC.
 
Registration closes on 11/12/2018 at 11:00 PM
 

CONTINUING EDUCATION

843 488 5550 Office

843 488 5554 Fax

info@ahrevents.com Email

www.ahrevents.com Web

341 Wellness Drive, Myrtle Beach, SC 29579 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.